Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2009
02/26/2009US20090053747 Measurement of Haloperoxidase Activity With Chemiluminescent Detection
02/26/2009US20090053746 Fluorescence resonance energy transfer (Fret) on substrates comprising syntaxin or mimetics thereof; for clostridium and tetanus toxins
02/26/2009US20090053745 Methods and Kits for Regulation of Microtubule Assembly and Dendrite Growth and Branching
02/26/2009US20090053744 Luciferase Detection Assay System
02/26/2009US20090053738 Protease detection
02/26/2009US20090053730 Chimeric human t1r1 taste receptor polypeptides and compositions containing same
02/26/2009US20090053729 Method for detection of mutant gene
02/26/2009US20090053728 Analytical Method and Kit
02/26/2009US20090053727 Risk Assessment For Adverse Drug Reactions
02/26/2009US20090053726 Systems and methods for real-time pcr
02/26/2009US20090053725 Using DNA aptamers and quantum dots for the detection of proteins or other targets
02/26/2009US20090053724 System and method for adaptive reagent control in nucleic acid sequencing
02/26/2009US20090053723 Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS)
02/26/2009US20090053722 Sdad assay and uses thereof
02/26/2009US20090053721 Voltage-gated ion channel mutants for use in identifying ion channel modulating compounds
02/26/2009US20090053720 Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5'-3' nuclease activity
02/26/2009US20090053719 Analysis of nucleic acids by digital pcr
02/26/2009US20090053718 NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs
02/26/2009US20090053717 Methods and compositions for detecting spermatozoa or semen in a sample
02/26/2009US20090053716 Method of detecting human cytochrome p450 (cyp) 2d6 gene mutation
02/26/2009US20090053715 Methods of screening nucleic acids for single nucleotide variations
02/26/2009US20090053714 Gins gene expression as marker for actively cycling cells and cell cycle phase
02/26/2009US20090053713 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same
02/26/2009US20090053712 Methods of using LEDGF/p75
02/26/2009US20090053711 Pseudo-tissue for accuracy control, method for controlling accuracy by using the same, and method for manufacturing the same
02/26/2009US20090053710 Functional molecule, functional molecule synthesizing amidite and target substance analysis method
02/26/2009US20090053709 Enhanced sensitivity of a cantilever sensor via specific bindings
02/26/2009US20090053708 Method and/or Apparatus of Oligonucleotide Design and/or Nucleic Acid Detection
02/26/2009US20090053707 Methods for lightening skin and hair
02/26/2009US20090053706 Dna methylation markers associated with the cpg island methylator phenotype (cimp) in human colorectal cancer
02/26/2009US20090053705 Methods for increasing accuracy of nucleic acid sequencing
02/26/2009US20090053704 Stabilization of nucleic acids on solid supports
02/26/2009US20090053703 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
02/26/2009US20090053702 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
02/26/2009US20090053701 Detectable nucleic acid tag
02/26/2009US20090053700 Optical sorting method
02/26/2009US20090053699 Method for Preparing Polynucleotides for Analysis
02/26/2009US20090053698 Method for obtaining subtraction polynucleotide
02/26/2009US20090053697 Pharmacological Applications of Mitochondrial DNA Assays
02/26/2009US20090053696 Biomarker For Heart Failure
02/26/2009US20090053695 Gene Marker and Use Thereof
02/26/2009US20090053694 Photochemically Amplified Bioassay
02/26/2009US20090053693 Identification of polymorphisms in the epcr gene associated with thrombotic risk
02/26/2009US20090053692 Detection of hiv-1 by nucleic acid amplification
02/26/2009US20090053691 Cell Line and Methods for Determining Viral Titer
02/26/2009US20090053690 Surface chemistry and deposition techniques
02/26/2009US20090053689 Device for processing a biological and/or chemical sample and method of using the same
02/26/2009US20090053688 method and device for ultrasound assisted particle agglutination assay
02/26/2009US20090053687 Method for the detection of hpv and probes, primers and kits
02/26/2009US20090053360 Gene encoding glycogen synthase and use thereof
02/26/2009US20090053359 Ammonia transporter gene and use thereof
02/26/2009US20090053358 Sulfate Ion Transporter Gene and Use Thereof
02/26/2009US20090053343 Kits and Methods for Assessing Leptin-Mediated Lipid Metabolism
02/26/2009US20090053298 constitutive active/androstane receptor (CAR); antisense agents; drug screening; hepatocytes
02/26/2009US20090053296 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN)
02/26/2009US20090053295 Regulatable fusion promoters
02/26/2009US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
02/26/2009US20090053258 Assays for diagnosis of tuberculosis and uses thereof
02/26/2009US20090053253 Process for the measurement of the potency of glatiramer acetate
02/26/2009US20090053244 Modified vaccinia virus strains for use in diagnostic and therapeutic methods
02/26/2009US20090053239 ACACS As Modifiers of the IGF Pathway and Methods of Use
02/26/2009US20090053231 Optical Disc Apparatus
02/26/2009US20090053227 Prostate Specific Genes and The Use Thereof in Design of Therapeutics
02/26/2009US20090053209 Blockade of Pin1 Prevents Cytokine Production by Activated Immune Cells
02/26/2009US20090053207 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas
02/26/2009US20090053201 Using variation in DNA polymerase sequence as diagnostic indicator of adefovir or tenofovir resistance in virus; viricides
02/26/2009US20090053200 Method for retarding unhealth manifestations brought by ageing of human beings
02/26/2009US20090053196 Chn-1/Chip-Antagonists For The Treatment Of Muscular Diseases
02/26/2009US20090053195 Biomarkers for acute graft rejection
02/26/2009US20090053194 Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent
02/26/2009US20090053191 Phospholipases, nucleic acids encoding them and methods for making and using them
02/26/2009US20090053181 Modulation of Cells
02/26/2009US20090053136 Therapeutic immunoglobulin specific for lymphocyte adhesion protein for killing and/or inhibiting growth of cancer cells
02/26/2009DE102005011003B9 Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren Method and means for the differential diagnosis of thyroid tumors
02/26/2009DE102005002672B4 Verfahren zur schnellen Differenzierung von Mikroorganismen auf Subspezies-Ebene mittels MALDI-TOF MS A method for the rapid differentiation of microorganisms on subspecies level by MALDI-TOF MS
02/26/2009CA2698212A1 Methods and compositions for diagnosing disease
02/26/2009CA2697668A1 New molecular markers for detection of squamous cell carcinomas and adenocarcinomas and high-grade precursor lesions thereof
02/26/2009CA2697112A1 Male reproductive health panel and uses thereof
02/26/2009CA2696995A1 Identification of human t2r receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof
02/26/2009CA2696801A1 Generation of neuronal cells from pluripotent stem cells
02/26/2009CA2696698A1 Enriched nanostructure composition
02/26/2009CA2696403A1 Methods of using mirna for detection of in vivo cell death
02/26/2009CA2696402A1 Methods for diagnosis, prognosis and methods of treatment
02/26/2009CA2696083A1 An enzyme detection device
02/26/2009CA2695420A1 Methods for detecting oligonucleotides
02/26/2009CA2694703A1 Gene expression markers of recurrence risk in cancer patients after chemotherapy
02/26/2009CA2694476A1 Permissive cells and uses thereof
02/26/2009CA2693655A1 Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer
02/26/2009CA2693361A1 Process
02/25/2009EP2028493A1 Procalcitonin 3-116
02/25/2009EP2028278A1 RNA sequence-specific mediators of RNA interference
02/25/2009EP2028274A2 An antisense oligonucleotide against the TGF-beta2 gene
02/25/2009EP2028273A1 Method for detecting uro-genital infection, oligonucleotide, oligonucleotide combination, biochip and a set based thereon
02/25/2009EP2028270A2 Modified recombinant vaccina viruses and uses thereof
02/25/2009EP2028269A1 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or Exendin-4 and uses thereof
02/25/2009EP2028250A1 Luminescence enhancer
02/25/2009EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer
02/25/2009EP2028187A1 Human and mouse targeting peptides identified by phage display
02/25/2009EP2027914A2 Biochip
02/25/2009EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment